PROTIA Accelerates Entry into the Americas Diagnostics Market through Successful Participation in ADLM 2025

PROTIA successfully participated in ADLM 2025 (Association for Diagnostics & Laboratory Medicine, formerly AACC), the world’s largest clinical diagnostics exhibition, held from July 27 to 31 at McCormick Place in Chicago, USA, marking a significant step forward in its strategic expansion into the Americas diagnostics market.

As a global gathering of clinical diagnostics and laboratory medicine professionals, ADLM provided an ideal platform for PROTIA to showcase its flagship multiplex allergy diagnostic kit and a range of innovative diagnostic solutions with proprietary technological advantages, reinforcing its competitive edge in the global market.

Through this exhibition, PROTIA identified the U.S., Canada, Mexico, and Brazil as strategic markets and focused on strengthening local distribution networks and expanding partnerships across the Americas.

Among the highlights was PROTIA Allergy-Q 192D, a high-performance multiplex allergy test that can precisely analyze 176 allergen responses—including food, pollen, mold, drug allergens such as penicillin shock, and recombinant protein allergens—with a single blood test. The product was praised for its diagnostic accuracy and efficiency, and customizable panels (40, 60, 100, 120, and 180 allergens) were offered to meet various customer needs.

In addition, PROTIA unveiled the following innovative diagnostic products:

• PROTIA Allergy-Q 192D: Multiplex allergy test for 176 allergens

• PROTIA Food IgG: Specific IgG-mediated delayed food intolerance test

• PROTIA AST: Next-generation antimicrobial susceptibility test reducing turnaround time from 3 days to 1 and doubling antibiotic coverage (up to 40 types)

• PROTIA ANA Profile 18: Multiplex autoimmune panel for 18 diseases

With its participation in ADLM 2025, PROTIA significantly enhanced its brand visibility across the Americas and laid a stronger foundation for global expansion through local partnership development and market-specific product strategies.